Evidence map›Paper›PMID 21709606›Full record

ArticleTransplantation2011

Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.

Fabrice Porcheray, David B Miklos, Blair H Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J Soiffer, Joseph H Antin, Edwin P Alyea, Jerome Ritz, Emmanuel Zorn

Abstract read
In one paragraph

Article in Transplantation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. B cells in chronic graft-versus-host disease.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2015
    Review
  11. Clinical impact of H-Y alloimmunity.Immunologic research · 2014
    Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Fabrice PorcherayDepartment of Surgery, Transplant Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
David B Miklos
Blair H Floyd
Stefanie Sarantopoulos
Roberto Bellucci
Robert J Soiffer
Joseph H Antin
Edwin P Alyea
Jerome Ritz
Emmanuel Zorn
Harvard University · USMassachusetts General Hospital · USStanford Medicine · US

Funding

Trageting the Multiple Myeloma EpigenomeP50CA100707 · NCI · DANA-FARBER CANCER INSTITUTE · PI MUNSHI, NIKHIL C. · 2003 to 2023
$45.0M
Targeting Genomic Instability and Evolution in MyelomaP01CA155258 · NCI · DANA-FARBER CANCER INST · PI Charles B Epstein · 2011 to 2026
$32.5M
Targeting Myeloma Cell-Host Bone Marrow InteractionsP01CA078378 · NCI · DANA-FARBER CANCER INSTITUTE · PI ANDERSON, KENNETH C. · 1998 to 2014
$26.2M
Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host DiseaseP01CA142106 · NCI · DANA-FARBER CANCER INST · PI CUTLER, COREY S · 2009 to 2019
$17.5M
Physician Scientist Training in Cancer ResearchT32CA009172 · NCI · DANA-FARBER CANCER INSTITUTE · PI Jennifer R Brown, James A. DeCaprio · 1985 to 2026
$17.1M
Reconstitution of Regulatory T Cells after Allogeneic Stem Cell TransplantationU19AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SOIFFER, ROBERT JON · 2005 to 2010
$9.0M
Role of Cytokines in Myeloma PathogenesisR01CA050947 · NCI · DANA-FARBER CANCER INSTITUTE · PI ANDERSON, KENNETH C., MITSIADES, CONSTANTINE S. · 1991 to 2018
$5.1M
T CELL NEOGENESIS AFTER STEM CELL TRANSPLANTATIONP01AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI RITZ, JEROME · 1990 to 2003
$4.5M
Immune Deregulation and Chronic Humoral Rejection of Kidney Allografts in HumansR01DK083352 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ZORN, EMMANUEL · 2010 to 2014
$2.1M
NCI NIH HHS CA142106NCI NIH HHS P01 CA078378NCI NIH HHS P01 CA142106NCI NIH HHS P01 CA155258NCI NIH HHS P50 CA100707NCI NIH HHS R01 CA050947NCI NIH HHS T32 CA009172NIAID NIH HHS AI29530NIAID NIH HHS P01 AI029530NIAID NIH HHS U19 AI029530NIDDK NIH HHS R01 DK083352
6 · The paper itself

Abstract

backgroundAntibody responses to HY antigens in male recipients are frequent after transplantation of stem cells from female donors (Miklos et al., Blood 2005; 105: 2973; Miklos et al., Blood 2004; 103: 353). However, evidence that this B-cell immunity is accompanied by T-cell responses to the cognate antigens is scarce. Here, we examined T- and B-cell responses to DBY antigen in a male patient who received hematopoietic stem cells from a human leukocyte antigen-identical female sibling. MATERIALS AND

methodsWe used 93 overlapping peptides representing the entire DBY protein to detect and characterize T-cell and antibody responses to DBY by enzyme-linked immunosorbent spot (ELISPOT) and enzyme-linked immunosorbent assay.

resultsHigh frequency CD4+ T cells specific for a unique DBY peptide were detected in the patient blood. We isolated the corresponding T-cell clone and characterized the recognized epitope as an 18-mer peptide restricted by human leukocyte antigen-DRB1*0101. Upon stimulation, this clone produced cytokines with no evidence of Th1 or Th2 polarization. Remarkably, this clone also recognized the DBX homologue peptide and responded to female donor dendritic cells stimulated with poly I/C or lipopolysaccharide, indicating that the peptide was endogenously processed in these cells. High titer DBY-specific antibodies were also found in the patient serum which, in contrast to the T-cell response, did not cross-react with DBX.

conclusionWe show here the development of a coordinated B and T-cell response to DBY in a recipient of sex mismatched allogeneic hematopoietic stem-cell transplantation. Our findings support a role for CD4+ T cells in the development of humoral immunity to minor histocompatibility antigens.

Indexed as

Antibody SpecificityAntigen-Antibody ReactionsB-LymphocytesCD4-Positive T-LymphocytesCytokinesDEAD-box RNA HelicasesDendritic CellsFemaleHistocompatibility TestingHumansIsoantibodiesMaleMiddle AgedMinor Histocompatibility AntigensSex FactorsStem Cell TransplantationCytokinesDDX3X protein, humanDDX3Y protein, humanDEAD-box RNA HelicasesIsoantibodiesMinor Histocompatibility Antigens

Identifiers

PMID21709606
PMCPMC3263512
OpenAlexW2078352144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.